Lizobakt Medication, instructions for usewhich describes in detail its action and composition, is a preparation in the form of tablets, intended for resorption in the oral cavity. Its main components are lysozyme (lysozyme hydrochloride) and pyridoxine (pyridoxine hydrochloride). The first of these substances, an enzyme with antiseptic properties, has an antibacterial effect. Destroying the cellular membranes of pathogenic viruses, fungi and bacteria, it causes disruption of their functions and, ultimately, death. For the human body, lysozyme is a habitual and natural substance: it is contained in saliva, the mucous membrane of the digestive tract, the mucous secret of the upper respiratory tract - that is, in places that can become the gateway to infection. Its concentration is high in breast milk - several times more than in cow's milk.

Pyridoxine or vitamin B6 is also givenan important role in the preparation "Lizobakt": the instruction for use suggests that this substance promotes the regeneration of infected mucous membranes. In addition, pyridoxine is a strong antioxidant, stimulates metabolism and participates in the synthesis of erythrocytes. The drug "Lizobakt", the instruction for its use contains complete information about its properties, is thus an effective tool for the treatment and prevention of infectious diseases of the larynx of the larynx and the oral cavity.

Treatment with the drug "Lizobakt" is hisslow resorption. Children over 12 years and adults are prescribed two tablets three to four times a day. They should be kept in the mouth before dissolving and for at least half an hour after that do not eat or drink. The recommended dose of this drug for children 3-7 years is one tablet three times a day, and 7-12 - four times a day. The approximate course of treatment is eight days, but if there are indications, the duration of taking the drug "Lizobakt" (instructions for use indicates this) can be prolonged by the attending physician. If necessary, the drug can be administered to children under three years of age: a tablet or a part thereof is triturated into powder.

Indications for use of the medicinal product"Lizobakt" are, first of all, infectious and inflammatory ENT diseases, accompanied by catarrhal phenomena. According to reviews, the condition of patients as a result of its application is improving already on the third or fourth day. Tablets "Lizobakt" in angina, at the same time, according to some patients, do not bring the desired result, but it should be understood that, firstly, the effect of their reception is not immediately apparent, and, secondly, they should be used in complex with other medicines: this medicine alone can not cure a sore throat. With stomatitis, including herpetic and aphthous, and erosions of the oral mucosa, its effect is quite effective.

The drug "Lizobakt" can be used forprevention of complications after removal of the tonsils. Some use it for prophylactic purposes and in the period of epidemics of acute respiratory infections, dissolving in the mouth in the morning, before leaving home. This drug is the only one of the few allowed to be taken during pregnancy. Tablets "Lizobakt" with breastfeeding are also not prohibited: pyridoxine in a small amount penetrates into the mother's milk, but is not able to harm the child.

However, the reviews speak of the possibilityallergic reactions to this drug. People who are prone to allergies should use it with caution, and if dryness in the mouth, itching, swelling of the mucous membranes or rash occurs, stop taking Lizobakt immediately and consult a doctor. In no case should the recommended dose be exceeded or taken longer than the doctor advises. Do not swallow tablets: they are intended for resorption, and the effect of their reception in this case will not be.

As for the interaction of the drug"Lizobakt" with other medicines, it must be remembered: with simultaneous administration with a number of antibacterial drugs (chloramphenicol, penicillin), it is able to enhance the effect of their use. In addition, persons suffering from Parkinson's disease should bear in mind that the drug "Lizobakt" reduces the effectiveness of levodopa.